- Home
- KLTOW vs TDY Comparison
KLTOW vs TDY Comparison
Compare KLTOW & TDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- TDY
- Stock Information
- Founded
- KLTOW N/A
- TDY 1960
- Country
- KLTOW United States
- TDY United States
- Employees
- KLTOW 3
- TDY N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- TDY Industrial Machinery/Components
- Sector
- KLTOW Health Care
- TDY Industrials
- Exchange
- KLTOW Nasdaq
- TDY Nasdaq
- Market Cap
- KLTOW N/A
- TDY N/A
- IPO Year
- KLTOW 2022
- TDY 1999
- Fundamental
- Price
- KLTOW $0.02
- TDY $462.19
- Analyst Decision
- KLTOW
- TDY Strong Buy
- Analyst Count
- KLTOW 0
- TDY 5
- Target Price
- KLTOW N/A
- TDY $548.00
- AVG Volume (30 Days)
- KLTOW N/A
- TDY 316.4K
- Earning Date
- KLTOW N/A
- TDY 04-23-2025
- Dividend Yield
- KLTOW N/A
- TDY N/A
- EPS Growth
- KLTOW N/A
- TDY N/A
- EPS
- KLTOW N/A
- TDY 17.21
- Revenue
- KLTOW N/A
- TDY $5,670,000,000.00
- Revenue This Year
- KLTOW N/A
- TDY $7.37
- Revenue Next Year
- KLTOW N/A
- TDY $5.37
- P/E Ratio
- KLTOW N/A
- TDY $26.86
- Revenue Growth
- KLTOW N/A
- TDY 0.61
- 52 Week Low
- KLTOW N/A
- TDY $355.41
- 52 Week High
- KLTOW N/A
- TDY $522.50
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- TDY 42.64
- Support Level
- KLTOW N/A
- TDY $457.15
- Resistance Level
- KLTOW N/A
- TDY $474.54
- Average True Range (ATR)
- KLTOW 0.00
- TDY 18.02
- MACD
- KLTOW 0.00
- TDY -0.47
- Stochastic Oscillator
- KLTOW 0.00
- TDY 51.66
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.